Trimethoprim-induced hyperkalemia in burn patients treated with intravenous or oral trimethoprim sulfamethoxazole for methicillin-resistant staphylococcus aureus and other infections: Nature or nurture?

Journal of Burn Care and Research

Volumn 34, Issue 1, 2013, Pages 127-132

  Ackerman, Bruce H ^a   Patton, Mary L ^a   Guilday, Robert E ^a   Haith, Linwood R ^a   Stair Buchmann, Megan ^a   Reigart, Cynthia L ^a  

^a CROZER CHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; LINEZOLID; POTASSIUM; TRIMETHOPRIM;

ADULT; ARTICLE; CREATININE CLEARANCE; FEMALE; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; THERMAL INJURY;

ADMINISTRATION, ORAL; ADULT; BURNS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERKALEMIA; INJECTIONS, INTRAVENOUS; INJURY SEVERITY SCORE; LENGTH OF STAY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; SURVIVAL RATE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; WOUND INFECTION;

EID: 84873839592     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3182700b18     Document Type: Article

References (28)

1. Stein A, Bataille JF, Drancourt M, et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998;42:3086-91.
2. Unal S, Ersoz G, Demirkan F, Arslan E, Tütüncü N, Sari A. Analysis of skin-graft loss due to infection: infection-related graft loss. Ann Plast Surg 2005;55:102-6.
3. Phillips S, MacDougall C, Holdford DA. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillinresistant Staphylococcus aureus. Ann Pharmacother 2007; 41:13-20.
4. Palmieri TL, Greenhalgh DG, Saffle JR, et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002;23:87-96.
5. Eiam-Ong S, Kurtzman NA, Sabatini S. Studies on the mechanism of trimethoprim-induced hyperkalemia. Kidney Int 1996;49:1372-8.
6. Perlmutter EP, Sweeney D, Herskovits G, Kleiner M. Case report: severe hyperkalemia in a geriatric patient receiving standard doses of trimethoprim-sulfamethoxazole. Am J Med Sci 1996;311:84-5.
7. Mori H, Kuroda Y, Imamura S, et al. Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole. Intern Med 2003;42: 665-9.
8. Margassery S, Bastani B. Life threatening hyperkalemia and acidosis secondary to trimethoprim-sulfamethoxazole treatment. J Nephrol 2001;14:410-4.
9. Perazella MA. Drug-induced hyperkalemia: old culprits and new offenders. Am J Med 2000;109:307-14.
10. Perazella MA. Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management. Drug Saf 2000;22:227-36.
11. Marinella MA. Trimethoprim-induced hyperkalemia: an analysis of reported cases. Gerontology 1999;45:209-12.
12. Elisaf M, Terrovitou C, Tomos P, Siamopoulos KC. Severe hyperkalaemia after cotrimoxazole administration in a patient with hyporeninaemic hypoaldosteronism. Nephrol Dial Transplant 1997;12:1254-5.
13. Alappan R, Buller GK, Perazella MA. Trimethoprimsulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem? Am J Nephrol 1999;19:389-94.
14. Pina G, Brun J, Tissot S, Claustrat B. Long-term alteration of daily melatonin, 6-sulfatoxymelatonin, cortisol, and temperature profiles in burn patients: a preliminary report. Chronobiol Int 2010;27:378-92.
15. Murton SA, Tan ST, Prickett TC, Frampton C, Donald RA. Hormone responses to stress in patients with major burns. Br J Plast Surg 1998;51:388-92.
16. Mayan H, Kantor R, Farfel Z. Trans-tubular potassium gradient in patients with drug-induced hyperkalemia. Nephron 2001;89:56-61.
17. Preston RA, Hirsh MJ MD, Oster MD Jr, Oster HR MD. University of Miami Division of Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia. Am J Ther 1998;5:125-32.
18. Fuchs PCh, Groger A, Bozkurt A, Johnen D, Wolter T, Pallua N. Cortisol in severely burned patients: investigations on disturbance of the hypothalamic-pituitary-adrenal axis. Shock 2007;28:662-7.
19. Dugan AL, Malarkey WB, Schwemberger S, Jauch EC, Ogle CK, Horseman ND. Serum levels of prolactin, growth hormone, and cortisol in burn patients: correlations with severity of burn, serum cytokine levels, and fatality. J Burn Care Rehabil 2004;25:306-13.
20. Sheehan MT, Wen SF. Hyperkalemic renal tubular acidosis induced by trimethoprim/sulfamethoxazole in an AIDS patient. Clin Nephrol 1998;50:188-93.
21. Cheng H, Harris RC. Potential side effects of renin inhibitors-mechanisms based on comparison with other renin-angiotensin blockers. Expert Opin Drug Saf 2006;5: 631-41.
22. Letavernier E, Couzi L, Delmas Y, Moreau K, Murcott O, de Précigout V. Verapamil and mild hyperkalemia in hemodialysis patients: a potentially hazardous association. Hemodial Int 2006;10:170-2.
23. Matthews JM. Succinylcholine-induced hyperkalemia. Anesthesiology 2006;105:430; author reply 431.
24. Koren-Michowitz M, Avni B, Michowitz Y, Moravski G, Efrati S, Golik A. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study. Pharmacoepidemiol Drug Saf 2004;13:299-302.
25. Gheno G, Cinetto L, Savarino C, Vellar S, Carraro M, Randon M. Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin. Eur J Clin Pharmacol 2003;59:373-7.
26. Orlando MP, Dillon ME, O'Dell MW. Heparin-induced hyperkalemia confirmed by drug rechallenge. Am J Phys Med Rehabil 2000;79:93-6.
27. Wiggam MI, Beringer TR. Effect of low-molecular-weight heparin on serum concentrations of potassium. Lancet 1997;350:292-3.
28. al-Zaki T, Taibot-Stern J. A bodybuilder with diuretic abuse presenting with symptomatic hypotension and hyperkalemia. Am J Emerg Med 1996;14:96-8.